Skip to main content
CYCLOPHARM LIMITED logo

CYCLOPHARM LIMITED — Investor Relations & Filings

Ticker · CYC ISIN · AU000000CYC5 LEI · 9845008C9R4608FB7007 ASX Manufacturing
Open in API
Filings indexed 777 across all filing types
Latest filing 2021-05-20 Major Shareholding Noti…
Country AU Australia
Listing ASX CYC

About CYCLOPHARM LIMITED

https://www.cyclopharm.com.au

Cyclopharm Limited focuses on the development and commercialization of specialized medical imaging technologies. Its primary product, Technegas, is an ultra-fine dispersion of carbon nano-particles labeled with Technetium-99m, utilized for functional lung ventilation imaging. This technology is used to diagnose Pulmonary Embolism by providing high-resolution images via the inhalation of a radioactive aerosol. Technegas is generated on-site using proprietary equipment and is compatible with SPECT and SPECT/CT imaging. The system is engineered to provide diagnostic clarity even in patients with underlying airway diseases. Beyond its primary diagnostic use, the company investigates applications for its technology in managing chronic obstructive pulmonary disease (COPD), asthma, and lung cancer.

Recent filings

Filing Released Lang Actions
Becoming a substantial holder from MS 7 pages 520.2KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 under the Corporations Act 2001 Section 671B, titled 'Notice of initial substantial holder'. It details the substantial shareholding of Morgan Stanley and its subsidiaries in Cyclopharm Limited, including voting power, relevant interests, registered holders, consideration paid, and associates. This form is a regulatory notification about a change in significant share ownership levels, specifically a substantial holder notice. It is not a financial report, earnings release, or management report. It fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds.
2021-05-20 English
Ceasing to be a substantial holder from MS 6 pages 410.8KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 605' and is a 'Notice of ceasing to be a substantial holder' under the Corporations Act 2001, Section 671B. It details changes in relevant interests of a substantial holder (Morgan Stanley and its subsidiaries) in the voting securities of Cyclopharm Limited. The document includes dates of changes, nature of changes, and associated parties. It is a regulatory filing notifying the company and the market about changes in substantial shareholding, not a financial report, earnings release, or management discussion. It fits the definition of a Major Shareholding Notification (MRQ) as it reports changes in significant share ownership levels crossing thresholds. The document length and content confirm it is not a brief announcement or a report publication notice but a formal notification of shareholding changes.
2021-05-19 English
Ceasing to be a substantial holder from MUFG 3 pages 865.8KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 Notice of ceasing to be a substantial holder under the Corporations Act 2001 Section 671B. It details changes in relevant interests of a substantial shareholder, Mitsubishi UFJ Financial Group, Inc., including dates and nature of changes in shareholding. The document is regulatory in nature, reporting changes in significant share ownership levels, which aligns with the definition of Major Shareholding Notification (MRQ). The document is not a financial report, earnings release, or management discussion, but a formal notification of shareholding changes.
2021-05-19 English
Becoming a substantial holder from MUFG 9 pages 792.4KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 603' and is described as a 'Notice of initial substantial holder' under the Corporations Act 2001 Section 671B. It details the substantial shareholding of Mitsubishi UFJ Financial Group, Inc. in Cyclopharm Limited, including voting power percentages, relevant interests, registered holders, consideration paid, and associates. This type of filing is a notification of a major shareholding or change in significant ownership levels, which aligns with the definition of 'Major Shareholding Notification' (Code: MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure of shareholding interests. Therefore, the correct classification is MRQ with high confidence.
2021-05-18 English
Ceasing to be a substantial holder from MS 6 pages 192.7KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 605' and is a 'Notice of ceasing to be a substantial holder' under the Corporations Act 2001 Section 671B. It details changes in relevant interests of a substantial holder (Morgan Stanley and its subsidiaries) in the voting securities of Cyclopharm Limited. The document includes dates of changes, nature of changes, and associated parties. This type of filing is a notification about changes in significant share ownership levels, specifically ceasing to be a substantial holder. It is not a financial report, earnings release, or management report, but a regulatory notification about shareholding changes. Therefore, the appropriate classification is Major Shareholding Notification (MRQ). The document length and detail support this classification with high confidence.
2021-05-17 English
Ceasing to be a substantial holder from MUFG 3 pages 834.9KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 Notice of ceasing to be a substantial holder under the Corporations Act 2001 Section 671B. It details changes in relevant interests of a substantial shareholder, Mitsubishi UFJ Financial Group, Inc., including dates and nature of changes in shareholding. The document includes annexures with further details on share transactions and agreements related to voting rights. This type of filing is a notification of changes in significant share ownership levels, which aligns with the definition of Major Shareholding Notification (MRQ). The document is not a financial report, earnings release, or management report, but a regulatory notice about shareholding changes.
2021-05-17 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.